1Libby P,Ridker PM,Maseri A.Inflammation and atherosclerosis[J].Circulation,2002,105:1135-1143.
2Liuzzo G,Biasucci LM,Gallimore JR,et al.The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina[J].N Engl J Med,1994,331:417-424.
3Liuzzo G,Buffon A,Biasucci LM,et al.Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina[J].Circulation 1998;98:2370-2376.
4Lagrand WK,Niessen HW,Wolbink GJ,et al.C-reactive protein colocalizes with complement in human hearts during acute myoc-ardial infarction[J].Circulation,1997,95:97-103.
3[1]Van der Wal AC,Backer AE.Atherosclerotic plaque rupture pathologic basis of plaque stability and instability[J].Cardiovase Res,1999,41:334-344.
4[2]Jialal I,Devaraj S.Inflammation and atherosclerosis:the value of the high-sensitivity C-reactive protein assay as a risk marker[J].Am J Clin Pathol,2001,116(Suppl):108-115.
5[4]Virmani R,Kolodgie FD,Burke AP,et al.Lessons from sudden coronary death:a comprehensive morphological classification scheme for atherosclerotic lesions[J].Arterioscler Thromb Vase Biol,2000,20:1262-1275.
6[6]Naghavi M,Libby P,Falk E,et al.From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies:Part I[J].Circulation,2003,108:1664-1672.
7[7]Naghavi M,Libby P,Falk E,et al.From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies:Part II[J].Circulation,2003,108:1772-1778.
8[8]Li JJ,Fang CH.C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases[J].Med Hypotheses,2004,62:499-506.
9Rackley CE.Cardiovascular basis for cholesterol therapy.Cardiol Rev,2000,8:124-131.
10Nicholls SJ,Tuzcu EM.Sipahi I,et al.Effects of obesity on lipid-lowering,anti-inflammatory,and antiatheroscterotic benefits of atorvastatin or pravastatin in patients with coronary artery disease(from the REVERSAL Study).Am J Cardiol,2006,97(11):1553-1557.
